RxDoctor Payments Data

Evan Branscum, MD

Family Medicine · Harrison, ARNPI 1437679651

Payments from drug & device makers

$746in general payments, 2019–2025

Across 45 payments — averaging $16.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$214
  • Amgen$129
  • AstraZeneca$101
  • Phathom Pharmaceuticals, Inc.$47
  • Biogen$45
  • Astellas Pharma US Inc$34
  • plus $176 from 8 others

What the payments were for

  • Food & beverage$746100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$746 in reported general payments places this provider in the 50th percentile of 1,347 family medicine providers in Arkansas.

See all family medicine providers in Arkansas

Medicare billing

Part B allowed, 2024
$127,893
Medicare patients
370
Services billed
3,299

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
SkyclarysOmaveloxolone12$389,477
EliquisApixaban129$116,498
OzempicSemaglutide85$113,775
Trelegy ElliptaFluticasone/Umeclidin/Vilanter56$70,078
RybelsusSemaglutide37$62,686
JanuviaSitagliptin Phosphate32$43,177
JardianceEmpagliflozin42$42,207
MounjaroTirzepatide34$40,355
XareltoRivaroxaban15$18,728
LinzessLinaclotide14$12,636
MyrbetriqMirabegron19$12,182
Lantus SolostarInsulin Glargine,hum.Rec.Anlog83$10,911
Tresiba Flextouch U-200Insulin Degludec14$9,990
SymbicortBudesonide/Formoterol Fumarate23$9,355
Aimovig AutoinjectorErenumab-Aooe13$9,163

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
BiogenSkyclarys$45$389,47712 claims
Novo NordiskOzempic, Rybelsus$32$176,461122 claims
PfizerEliquis$11$116,498129 claims
GSKTrelegy Ellipta, Breo Ellipta$214$75,79269 claims
Boehringer IngelheimJardiance$18$42,20742 claims
AbbVieLinzess$15$12,63614 claims
Astellas Pharma US IncMyrbetriq$34$12,18219 claims
AstraZenecaSymbicort$101$9,35523 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 1,347 family medicine providers in Arkansas.

Other family medicine in Harrison

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →